$314 Million is the total value of Krensavage Asset Management, LLC's 11 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 18.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| REGN | Buy | REGENERON PHARMACEUTICALS | $46,046,000 | -7.4% | 82,258 | +3.2% | 14.66% | +8.4% |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $45,380,000 | -18.0% | 396,575 | -19.6% | 14.45% | -4.1% |
| UTHR | Sell | UNITED THERAPEUTICS CORP | $43,048,000 | -24.7% | 426,215 | -9.8% | 13.70% | -11.9% |
| BIIB | Sell | BIOGEN INC | $38,910,000 | -4.0% | 137,163 | -9.4% | 12.39% | +12.4% |
| ENTA | Buy | ENANTA PHARMACEUTICALS INC | $37,784,000 | -1.4% | 825,329 | +8.2% | 12.03% | +15.4% |
| TARO | Buy | TARO PHARMACEUTICAL INDUS | $29,475,000 | -15.0% | 537,378 | +3.0% | 9.38% | -0.5% |
| MCK | Sell | MCKESSON CORP | $27,705,000 | -16.5% | 186,030 | -13.9% | 8.82% | -2.2% |
| ALKS | Buy | ALKERMES PLC | $26,055,000 | -14.2% | 1,572,395 | +0.5% | 8.30% | +0.4% |
| SRGA | New | SURGALIGN HOLDINGS INC | $11,315,000 | – | 6,251,208 | +100.0% | 3.60% | – |
| IVC | Buy | INVACARE CORP | $6,625,000 | +18.7% | 880,920 | +0.5% | 2.11% | +38.8% |
| ANAB | Sell | ANAPTYSBIO INC | $1,753,000 | -57.5% | 118,858 | -35.7% | 0.56% | -50.3% |
| RTIX | Exit | RTI SURGICAL HDS INC | $0 | – | -5,851,572 | -100.0% | -5.06% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2020-12-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITED THERAPEUTICS CORP | 36 | Q3 2023 | 18.1% |
| Enanta Pharmceuticals Inc | 35 | Q3 2023 | 16.7% |
| INVACARE CORP | 28 | Q3 2021 | 5.8% |
| RTI SURGICAL INC | 23 | Q2 2020 | 7.9% |
| MCKESSON CORP | 20 | Q3 2022 | 16.3% |
| BIOGEN INC | 19 | Q3 2023 | 16.0% |
| MERCK & CO. INC. | 18 | Q1 2019 | 11.1% |
| DIGIRAD CORP | 18 | Q1 2019 | 1.0% |
| REGENERON PHARMACEUTICALS | 16 | Q3 2023 | 16.1% |
| ALKERMES PLC | 16 | Q3 2023 | 14.1% |
View Krensavage Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SURGALIGN HOLDINGS, INC. | February 19, 2021 | 5,380,449 | 6.6% |
| RTI SURGICAL, INC. | February 14, 2019 | 3,852,567 | 6.1% |
| Aviragen Therapeutics, Inc. | February 15, 2018 | 2,292,058 | 5.9% |
| ENANTA PHARMACEUTICALS INC | February 15, 2017 | 883,902 | 4.6% |
| Biota Pharmaceuticals, Inc. | February 17, 2016 | 2,267,655 | 5.9% |
View Krensavage Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SCHEDULE 13G | 2024-02-27 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-15 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-16 |
| 13F-HR | 2023-02-15 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-17 |
| 13F-HR | 2022-02-15 |
View Krensavage Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.